關鍵詞:alnylam pharmaceuticals
簡介:世界*品牌alnylam pharmaceuticals原裝,質量保證,*。
我公司專業(yè)經(jīng)營進口胎牛血清、細胞因子、ELISA試劑盒、細胞、抗體、生物試劑、耗材、培養(yǎng)基、一抗、二抗、其產(chǎn)品吸附均勻,吸附性好,空白值低,孔底透明度高,代做ELISA實驗等。產(chǎn)品涉及分子生物學、細胞生物學、細菌學、遺傳學、免疫學、生物化學、蛋白質學、細胞治療、臨床應用等領域。全國范圍內(nèi)免費快遞運輸,如出現(xiàn)運輸質量問題,我們可以包退換貨。
產(chǎn)品介紹:alnylam pharmaceuticals
Alnylam公司是一家專注RNAi療法對基因定義的目標治療的新型生物制藥公司,Alnylam Pharmaceuticals開發(fā)創(chuàng)新療法和新藥物,患者的治療方案是有限的和他們的照顧者的威脅生命的疾病。
H57785 1308290-04-1 N-(4-Bromobenzyl)-4-methylbenzamide, 97%
H56748 4-Bromo-N-(2-bromo-5-nitrophenyl)benzenesulfonamide, 97%
H57764 349613-49-6 4-Bromo-N-(2-bromophenyl)benzamide, 97%
H57109 1097814-35-1 4-Bromo-2-chloro-N-(4-fluorobenzyl)aniline, 97%
H57595 1004185-21-0 4-Bromo-N-(2-chloro-4-methylphenyl)benzamide, 97%
H57446 67764-29-8 4-Bromo-N-(3-chlorophenyl)benzamide, 97%
H56158 N-(4-Bromo-2-chlorophenyl)-4-methoxybenzenesulfonamide, 97%
H56553 4-Bromo-N-(3,4-dichlorobenzyl)benzenesulfonamide, 97%
H56752 4-Bromo-N-(2,3-dichlorophenyl)benzenesulfonamide, 97%
H56442 102429-07-2 2-Bromo-2',4'-difluoroacetophenone, 97%
H56106 4-Bromo-N-(2,6-difluorophenyl)benzenesulfonamide, 97%
H33714 202920-07-8 12-Bromododecylphosphonic acid, 95%
H56326 1020929-55-8 2-Bromo-N-(3-fluorobenzyl)aniline, 97%
H56111 1019577-62-8 3-Bromo-N-(2-fluorobenzyl)aniline, 97%
H56142 1021101-38-1 3-Bromo-N-(3-fluorobenzyl)aniline, 97%
H57669 1019603-22-5 4-Bromo-N-(3-fluorobenzyl)-2-methylaniline, 97%
H57200 1019563-46-2 4-Bromo-N-(3-fluorobenzyl)-3-methylaniline, 97%
H57027 1019608-54-8 4-Bromo-N-(4-fluorobenzyl)-2-methylaniline, 97%
H57347 1019487-46-7 4-Bromo-N-(4-fluorobenzyl)-3-methylaniline, 97%
H57203 1019562-83-4 4-Bromo-2-fluoro-N-(3-fluorobenzyl)aniline, 97%
H57864 1019614-02-8 4-Bromo-2-fluoro-N-(4-fluorobenzyl)aniline, 97%
H57335 4-Bromo-3-fluoro-N-(4-fluorobenzyl)aniline, 97%
H57483 N-(2-Bromo-4-fluorophenyl)-2,5-dimethylbenzenesulfonamide, 97%
H57550 N-(4-Bromo-2-fluorophenyl)-2,5-dimethylbenzenesulfonamide, 97%
H57802 N-(2-Bromo-4-fluorophenyl)-4-(trifluoromethyl)benzamide, 97%
H57971 N-(2-Bromo-4-fluorophenyl)-4-(trifluoromethyl)benzenesulfonamide, 97%
H57672 N-(4-Bromo-2-fluorophenyl)-4-(trifluoromethyl)benzenesulfonamide, 97%
H56341 4-Bromo-N-(2-methoxy-4-nitrophenyl)benzenesulfonamide, 97%
H57413 22633-44-9 3-Bromomethyl-3-oxetanemethanol, 95%
H57735 2-(4-Bromo-3-methylphenylcarbamoyl)benzoic acid, 97%
H57506 349125-26-4 N-(4-Bromo-2-methylphenyl)-4-methylbenzamide, 97%
H57437 39267-79-3 3-Bromooxetane, 95%
H57124 1019323-14-8 N-(2-Bromophenyl)-2-chloropyridine-4-carboxamide, 95%
H57316 1019466-39-7 N-(3-Bromophenyl)-2-chloropyridine-4-carboxamide, 95%
H57017 1019372-53-2 N-(4-Bromophenyl)-2-chloropyridine-4-carboxamide, 95%
H57495 N-(3-Bromophenyl)-2,5-dimethylbenzenesulfonamide, 97%
H57942 N-(4-Bromophenyl)-2,5-dimethylbenzenesulfonamide, 97%
H57400 N-(2-Bromophenyl)-2-(trifluoromethyl)benzamide, 97%
H57382 N-(3-Bromophenyl)-2-(trifluoromethyl)benzamide, 97%
H57811 N-(2-Bromophenyl)-4-(trifluoromethyl)benzenesulfonamide, 97%
H57793 N-(3-Bromophenyl)-4-(trifluoromethyl)benzenesulfonamide, 97%
H33086 1174064-62-0 4-(4-Bromo-1H-pyrazol-1-yl)benzenesulfonyl chloride, 97%
H33550 4-(5-Bromo-2-pyridyloxy)benzenesulfonyl chloride, 95%
H33170 170727-02-3 3-Bromothiophene-2-sulfonyl chloride, 95%
H57518 20320-35-8 2-(tert-Butylcarbamoyl)benzoic acid, 97%
H57524 131418-15-0 N-n-Butyl-2-chloropyridine-4-carboxamide, 95%
H57741 588694-28-4 N-tert-Butyl-2-chloropyridine-4-carboxamide, 95%
H55741 3910-58-5 N-n-Butyl-4-methoxybenzylamine, 97%
H57184 N-n-Butyl-4-methoxy-N-phenylbenzenesulfonamide, 97%
H54571 4-[n-Butyl(methyl)carbamoyl]-2-chlorobenzeneboronic acid, 97%
H56501 544-16-1 n-Butyl nitrite, 95%
H54949 4-(4-n-Butylphenylcarbamoyl)-2-chlorobenzeneboronic acid, 97%
免責聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡有限公司-化工儀器網(wǎng)合法擁有版權或有權使用的作品,未經(jīng)本網(wǎng)授權不得轉載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權使用作品的,應在授權范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關法律責任。
- 本網(wǎng)轉載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉載時,必須保留本網(wǎng)注明的作品第一來源,并自負版權等法律責任。
- 如涉及作品內(nèi)容、版權等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關權利。